Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care makes insulin pumps and related diabetes technology for people with insulin-dependent diabetes. It last closed at $17.06 on Nov 17, down 7.68% on the day. The average 12-month price target from 4 analysts is $23.25 (+36.3% from the last close), with a high of $28.00 and a low of $20.00. Analyst consensus is Buy, based on the latest ratings from 4 firms (2 buy, 2 hold, 0 sell). In the past 30 days there were 1 dark pool print totaling $3.8M, the largest $3.8M.
Key Stats
Last 12 monthsNot reported for this period.
From TNDM's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 4 analysts who set a price target on TNDM in the past 90 days. The average target is $23.25, with a high of $28.00 and a low of $20.00, compared with the last close of $17.06.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 6 | Barclays | Target raised | Hold | $18 → $20 |
| Nov 6 | Wells Fargo | Target lowered | Buy | $27 → $25 |
| Oct 7 | Barclays | Initiated | Hold | $18 |
| Sep 30 | Citigroup | Target lowered | Hold | $21 → $20 |
| Sep 24 | Truist Securities | Target lowered | Buy | $35 → $28 |
Technical Analysis
The stock is 7% below its 20 day and 1% below its 50 day average. It is 10% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 46). The nearest support is the Pivot S1 at $16.52, and the nearest resistance the swing high (Jun 16) at $17.20.
| RSI (14) | 45.90 | Middle of its range | Neutral |
| MACD | 0.21 | Below its signal line | Bearish |
| Stochastic | 64.2 | Middle of its range | Neutral |
| ADX (14) | 15.1 | No clear trend | |
| Williams %R | -66.5 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | -60.7 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −3.3% | Change over 10 sessions | Bearish |
| ATR (14) | $1.41 | Typical daily range, 8.3% of price |
| RSI (14) | 47.38 | Middle of its range | Neutral |
| MACD | -0.23 | Above its signal line | Bullish |
| Stochastic | 31.9 | Middle of its range | Neutral |
| ADX (14) | 11.2 | No clear trend | |
| Williams %R | -77.7 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | -9.5 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −0.3% | Change over 10 sessions | Bearish |
| ATR (14) | $2.83 | Typical daily range, 16.6% of price |
What happened before
See how TNDM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How TNDM has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2013.
Whale Options Flow
90DNo whale options trades in TNDM in the last 90 days.
Dark Pool
30DTNDM Institutional Ownership
Full report →- ●127 buying vs 139 selling
- ▲Held by funds +3.3 pts
- ▼Funds holding -11
- ▲Superinvestors: 3 added, 0 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 269 | 280 | −3.9% |
| In funds' top 10 | 2 | 1 | +100.0% |
| Held by funds | 117.0% | 113.7% | +3.3 pts |
| New / increased | 38 / 89 | 48 / 96 | −11.8% |
| Reduced / sold out | 90 / 49 | 92 / 44 | +2.2% |
| Put/call ratio | 15.88 | 0.22 | +7044.4% |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TNDM is in one of them and how their past TNDM trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered TNDM in an article yet. Here's the latest on the wider market.
TNDM Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Sep 29, 2026 | Oct 12, 2026 | 13 d |
| Donald J TrumpExecutive branch | Sell | $15K – $50K | Jul 29, 2026 | Sep 22, 2026 | 55 d |
| Donald J TrumpExecutive branch | Buy | $15K – $50K | Jul 17, 2026 | Sep 22, 2026 | 67 d |
| Donald J TrumpExecutive branch | Sell | $1K – $15K | May 15, 2026 | Jul 1, 2026 | 47 d |
| Donald J TrumpExecutive branch | Other | $15K – $50K | Mar 30, 2026 | May 14, 2026 | 45 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Tandem Diabetes Care
Tandem Diabetes Care is a San Diego, California company that designs, develops and sells insulin delivery systems for people with diabetes. Its main products are insulin pumps, including the t:slim X2 and Mobi, along with single use supplies that connect to them. The company also offers software tools, such as Tandem Source, a data platform for users, caregivers and healthcare providers, and the Sugarmate app. Its customers are mainly people with type 1 diabetes and, in the United States, people with type 2 diabetes who need intensive insulin therapy.
- Headquarters
- San Diego, CA
- Founded
- 2008
- Website
- tandemdiabetes.com ↗







